SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-15-005412
Filing Date
2015-12-08
Accepted
2015-12-07 21:02:58
Documents
9
Period of Report
2015-12-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tbuff_8k.htm 8-K 81476
2 AMENDMENT NO. 1 TO THE AGREEMENT AND PLAN OF MERGER AND ARRANGEMENT, DATED AUGUS tbuff_ex2.htm EX-2.1 45628
3 AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF tbuff_ex21.htm EX-2.2 282930
4 SECOND AMENDED AND RESTATED FACILITY AGREEMENT tbuff_ex101.htm EX-10.1 1007629
5 SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT tbuff_ex102.htm EX-10.2 100981
6 AMENDED AND RESTATED SHARE SUBSCRIPTION AGREEMENT tbuff_ex103.htm EX-10.3 496303
7 PRESS RELEASE tbuff_ex991.htm EX-99.1 39496
8 pozen.jpg GRAPHIC 9450
9 tribute.jpg GRAPHIC 8953
  Complete submission text file 0001354488-15-005412.txt   2081279
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31198 | Film No.: 151273967
SIC: 2834 Pharmaceutical Preparations